Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Toronto, Brampton, Detroit MI, Ottawa, Winchester VA,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Toronto, Montreal, Trumbull CT, New Haven CT, Newton MA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase 1, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Toronto, Grand Rapids MI, New York NY, Boston MA,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase 1, Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Toronto, Hackensack NJ, New Haven CT, Halifax,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06988488

Phase 1, Phase 2, Recruiting

A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

for
EGFR-Mutant Non-Small Cell Lung Cancer
Location: Toronto
Sponsor: Voronoi, Inc

Sex: All

Age: 18+

Code: NCT07699328

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

for
Malignant Neoplasm
Location: Toronto, Montreal, St Louis MO, San Antonio TX
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07600749

Phase 1, Recruiting

Contrast-enhanced CBCT With C-arm HyperSight Technology

for
Advanced Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07648160

Recruiting

Using Tumor Models to Determine Treatments

for
Pancreatic Ductal Carcinoma, Advanced Cancer, Epithelial Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06813079

Phase 2, Recruiting

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC),
Location: Toronto, Houston TX, San Antonio TX,
Sponsor: ProteinQure Inc.

Sex: All

Age: 18+

Code: NCT07190469

Phase 1, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Toronto, Cleveland OH, Ottawa, Greenfield Park,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase 3, Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for
Uveal Melanoma
Location: Toronto, Grand Rapids MI, Baltimore MD, New York NY,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07015190

Phase 3, Recruiting

Study of How Safe and Effective Tarlatamab is in Brain Cancers

for
Astrocytic Tumor, Oligodendroglial Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06776250

Phase 2, Recruiting

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

for
Advanced Cancer, Pancreatic Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07636382

Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Toronto, London, Pittsburgh PA, Morgantown WV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting

A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas

for
Sarcoma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07014137

Phase 2, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Toronto, Montreal, Philadelphia PA, Fairfax VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

for
Castrate Resistance Prostate Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18 - 70+

Code: NCT06927635

Phase 2, Recruiting

Hypersight and Ethos In Pediatric Radiotherapy

for
Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 0 - 18

Code: NCT07528547

Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Toronto, Montreal, New York NY, Fairfax VA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase 3, Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma,
Location: Toronto, Dallas TX, San Antonio TX
Sponsor: Auricula Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07148128

Phase 1, Phase 2, Recruiting